PolicyBrief
H.R. 6594
119th CongressDec 10th 2025
Medical Device Recall Improvement Act of 2025
IN COMMITTEE

This act establishes new federal requirements for medical device recalls, mandating standardized electronic notifications, timely FDA review, and improved patient outreach strategies.

Janice "Jan" Schakowsky
D

Janice "Jan" Schakowsky

Representative

IL-9

LEGISLATION

New Recall Law Mandates Patient Notification for High-Risk Medical Devices, Creates Public Database

When a company recalls a car part, you get a letter. When they recall a bag of spinach, you see it on the news. But when a medical device that’s literally inside you or keeping you alive gets recalled? Sometimes that information can feel like it’s traveling via carrier pigeon.

The Medical Device Recall Improvement Act of 2025 is trying to fix that communication gap. This bill mandates that the Secretary of Health and Human Services (HHS) create a standard electronic format for all medical device recall notifications within two years. Once that format is ready, manufacturers must use it when submitting recall notices, and the system requires the government to review those notices within two business days. The goal is simple: speed up the information flow and make sure the right people—including patients—get the memo quickly.

The Standardized Alert System

Right now, recall notifications can be a bit of a mixed bag, which slows down hospitals and doctors trying to figure out what to do. This bill, detailed in Section 2, changes that by requiring a standardized electronic format. Think of it like finally getting everyone to use the same spreadsheet template instead of handwritten notes.

This mandatory format must include specific, non-negotiable data points: who made the device, why it’s being recalled, its unique identifier (like a VIN number for a device), and, crucially, specific information for patients about the risk and what actions they should take. For the manufacturers, this means new compliance pressure and tighter deadlines, but for the healthcare facilities, it means a huge reduction in administrative guesswork when a dangerous device surfaces.

Finally, A Public Recall Library

One of the biggest wins for transparency in this bill is the requirement for a public database. Section 2 mandates that HHS maintain a publicly accessible, downloadable electronic database populated with all these standardized recall notifications. If you’ve ever tried to track down safety information on an older medical implant, you know how difficult this can be. This database means that patients, researchers, and journalists can independently monitor device safety, cutting through the noise and making it easier to verify claims.

Closing the Patient Information Loop

Perhaps the most impactful change involves direct patient notification. The bill recognizes that for certain high-stakes devices, simply telling the doctor isn't enough. It requires that recall strategies for specific devices must include a plan to notify affected patients directly.

This applies to Class I or Class II recalls for Class II or Class III devices that are implanted in the body, are life-sustaining, life-supporting, or used significantly in children. If you have a pacemaker (an implanted, life-supporting device) that is recalled, the manufacturer must now instruct your doctor’s office or clinic to tell you, the patient, about the specific risks and next steps. While the bill clarifies that doctors and facilities don’t have to share your private information with the manufacturer, they are now required to share the risk information with you. This is a massive step forward for people relying on complex medical technology, ensuring they aren't the last to know about a critical safety issue.

The Cost of Better Communication

To make all this happen—building the database, creating the electronic format, and reviewing submissions—the bill authorizes specific funding through fiscal year 2030, starting with $6.7 million in 2026. This money is earmarked to help the regulatory bodies handle the new administrative load. If manufacturers fail to comply with these new submission and notification requirements, Section 3 amends existing law to make that failure a prohibited act under the Federal Food, Drug, and Cosmetic Act, opening them up to penalties. This puts real teeth behind the new deadlines and formats, ensuring compliance isn't optional.